Cleared Traditional

K133135 - IMPAX VOLUME VIEWING 3.0

K133135 is an FDA 510(k) clearance for IMPAX VOLUME VIEWING 3.0, manufactured by Agfa Healthcare N.V.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 154-day FDA review.

K133135 · Agfa Healthcare N.V. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2014
Decision
154d
Days
Class 2
Risk

K133135 is an FDA 510(k) clearance for the IMPAX VOLUME VIEWING 3.0. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Agfa Healthcare N.V. (Mortsel, BE). The FDA issued a Cleared decision on March 7, 2014 after a review of 154 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Agfa Healthcare N.V. devices

FDA 510(k) Submission Details - K133135

510(k) Number K133135 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 04, 2013
Decision Date March 07, 2014
Days to Decision 154 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d slower than avg
Panel avg: 107d · This submission: 154d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1151
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K133135.
CORONIS 5MP
K133984 · Barco N.V. · Mar 2014
NIO COLOR 2MP
K133663 · Barco N.V. · Mar 2014
SYNO MR NEUROLOGY, SYNGO MR ONCOLOGY, SYNGO. MR BREVIS, SYNGO MMR GENERAL
K133401 · Siemens Medical Solutions USA, Inc. · Mar 2014
ADVANCED VIEWER
K132763 · Brainlab AG · Feb 2014
SCENIUM
K133654 · Siemens Medical Solutions USA, Inc. · Feb 2014
SYNGO.VIA MI WORKFLOWS
K133644 · Siemens Medical Solutions USA, Inc. · Feb 2014